✦ LIBER ✦

Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System

✍ Scribed by Bruce R. Gordon MD; Sheryl F. Kelsey PhD; Peter C. Dau MD; Antonio M. Gotto Jr.; MD; Kevin Graham MD; D.Roger Illingworth MD; PhD; Jonathan Isaacsohn MD; Peter H. Jones MD; Susan F. Leitman MD; Stuart D. Saal MD; Evan A. Stein MD; PhD; Thomas N. Stern MD; August Troendle MD; Robert J. Zwiener MD

Book ID: 113979052
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 61 KB
Volume: 81
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(97)00947-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory familial hyperch

Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system

✍ Bruce R. Gordon; Sheryl F. Kelsey; David W. Bilheimer; David C. Brown; Peter C. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 894 KB

A new low density lipoprotein apheresis

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)

✍ Hiroshi Mabuchi; Ichiro Michishita; Mitsuaki Takeda; Hajime Fujita; Junji Koizum 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 631 KB

Long-term experience with extracorporeal

Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption

✍ Schulzeck, P. ;Olbricht, C.J. ;Koch, K.M. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 564 KB

Patients with familial hypercholesterolemia have a high incidence of coronary heart disease due to diet- and drug-resistant, elevated low-density lipoprotein cholesterol (LDL-C). Five patients with familial hypercholesterolemia and diet- and drug-resistant LDL-C greater than 230 mg/dl were treated b

Comparative long-term experience with im

Comparative long-term experience with immunoadsorption and dextran sulfate cellulose adsorption for extracorporeal elimination of low-density lipoproteins

✍ Knisel, W. ;Pfohl, M. ;M�ller, M. ;Besenthal, I. ;Nicuolo, A. ;Voelker, W. ;Risl 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 900 KB

Low-density lipoprotein apheresis using

Low-density lipoprotein apheresis using the liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy

✍ Bruce R. Gordon; Stuart D. Saal 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 2 views

A subset of patients with familial hypercholesterolemia (FH) have an inadequate lipid-lowering response to diet and drug treatment and should be considered for low-density lipoprotein (LDL)-apheresis therapy. This procedure selectively removes apolipoprotein B-containing particles [LDL, very-low-den

Direct adsorption of low-density lipopro

Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: Results of the first clinical long-term multicenter study using DALI apheresis

✍ T. Bosch; A. Lennertz; D. Schenzle; J. Dräger 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract Direct adsorption of lipoproteins (DALI) is the first low‐density lipoprotein (LDL)‐apheresis technique by which atherogenic LDL and lipoprotein(a) (Lp(a)) can be selectively removed from whole blood without plasma separation. The present study was performed to evaluate the efficacy, se